Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues.
about
Stem cells as cellular vehicles for gene therapy against glioblastomaT Lymphocyte Migration: An Action Movie Starring the Actin and Associated Actors.Linking morphodynamics and directional persistence of T lymphocyte migrationT Cell Interstitial Migration: Motility Cues from the Inflamed Tissue for Micro- and Macro-PositioningTyrosine kinases EnAbling adaptor molecules for chemokine-induced Rap1 activation in T cellsPathogenic CD4+ T cells in patients with asthma.Mucosal immunity and protection against HIV/SIV infection: strategies and challenges for vaccine design.Proliferative expansion and acquisition of effector activity by memory CD4+ T cells in the lungs following pulmonary virus infectionA critical role of IL-17 in modulating the B-cell response during H5N1 influenza virus infectionT lymphocyte subset abnormalities in the blood and lung in pulmonary arterial hypertension.Different features of Vδ2 T and NK cells in fatal and non-fatal human Ebola infections.CXCL12-induced chemotaxis is impaired in T cells from patients with ZAP-70-negative chronic lymphocytic leukemia.Lack of chemokine signaling through CXCR5 causes increased mortality, ventricular dilatation and deranged matrix during cardiac pressure overloadRole of tumor suppressor TSC1 in regulating antigen-specific primary and memory CD8 T cell responses to bacterial infection.The role of chemokines in the recruitment of lymphocytes to the liver.Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic virusesIn vivo regulation of Bcl6 and T follicular helper cell development.Selective loss of chemokine receptor expression on leukocytes after cell isolation.Generalized Lévy walks and the role of chemokines in migration of effector CD8+ T cells.Normalization of tumor microenvironment by neem leaf glycoprotein potentiates effector T cell functions and therapeutically intervenes in the growth of mouse sarcoma.Human papillomavirus 16-associated cervical intraepithelial neoplasia in humans excludes CD8 T cells from dysplastic epitheliumTherapy with recombinant T-cell receptor ligand reduces infarct size and infiltrating inflammatory cells in brain after middle cerebral artery occlusion in miceNonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities.Estradiol and G1 reduce infarct size and improve immunosuppression after experimental stroke.Bioprocess forces and their impact on cell behavior: implications for bone regeneration therapy.Characterization of effector and memory T cell subsets in the immune response to bovine tuberculosis in cattle.The serum CXCL13 level is associated with the Glasgow Prognostic Score in extranodal NK/T-cell lymphoma patientsImpact of interleukin-21 in the pathogenesis of primary Sjögren's syndrome: increased serum levels of interleukin-21 and its expression in the labial salivary glands.Phenotypic alterations in type II alveolar epithelial cells in CD4+ T cell mediated lung inflammation.Oral inflammatory diseases and systemic inflammation: role of the macrophage.Dendritic Cell-Like Cells Accumulate in Regenerating Murine Skeletal Muscle after Injury and Boost Adaptive Immune Responses Only upon a Microbial Challenge.Characterization of T cell repertoire of blood, tumor, and ascites in ovarian cancer patients using next generation sequencingRole of C-C chemokine receptor type 7 and its ligands during neuroinflammationElevated pretreatment serum levels of interferon-inducible protein-10 (CXCL10) predict disease relapse and prognosis in diffuse large B-cell lymphoma patients.Peripheral Organs of Dengue Fatal Cases Present Strong Pro-Inflammatory Response with Participation of IFN-Gamma-, TNF-Alpha- and RANTES-Producing Cells.Expression of the chemokine CCL28 in pleomorphic adenoma and adenolymphoma of the human salivary glandsQuantification of chemokines by real-time reverse transcriptase PCR: applications in type 1 diabetes.Human peripheral blood T regulatory cells (Tregs), functionally primed CCR4+ Tregs and unprimed CCR4- Tregs, regulate effector T cells using FasL.Clinical utilization of chemokines to combat cancer: the double-edged sword.SDF-1α degrades whereas glycoprotein 120 upregulates Bcl-2 interacting mediator of death extralong isoform: implications for the development of T cell memory
P2860
Q26771835-CC544412-D921-433F-98E2-070FBEF14188Q26774663-A1CDB30F-B359-4DC9-A6F6-FA59A5514F14Q27342886-FF26D482-C3AF-4903-B15C-6C03E010E32BQ28068792-48847990-435C-49C9-A92D-EDE7EF2E1E12Q28272316-969A842B-4E79-48D6-949E-6E3E6535FB77Q30252507-17FD50EB-5CCC-4F69-99B6-6E1BC4C92725Q30375160-182691B2-774D-4FAC-8D8A-62B40ED065CCQ30436432-D38F0335-E5D0-4E84-AAB7-710B8C224BCFQ33577691-15C5980B-349D-4EEB-B2AF-C3FB83E3BA97Q33679052-A371D5BD-DD8D-4019-B7AC-4A00B579B063Q33803364-04B5F703-5F22-4431-B43C-B51831281679Q33829089-F1B2DE04-589F-44E8-BF52-EEF67DB81C88Q33886486-747F4996-5B3A-453B-B411-1B098FEE51B7Q33899659-E0761A0C-BB22-42FB-A14C-FE0658A05F7CQ33906565-E1C282E8-1080-4520-A672-FC0217E1C030Q33924550-20D2833C-6FF5-4E04-91D0-F62F050141E9Q33936471-581317E5-9F58-4D1E-BDD4-D28E09794FABQ34189281-EF08C1CC-DD5A-40A5-8F48-9A58042E23F2Q34283399-33438FF6-6FAC-4D56-BCDF-644318C6FCAEQ34778932-856FC23F-67C6-4DD4-AD02-B27374F3A27CQ34788763-E350AB69-BE68-49DB-8017-2A236E788117Q35036755-0E4F73EB-6B18-41FC-9800-2B9455BDF37AQ35084580-05E69C5B-65E5-40C5-A66A-6272C130F681Q35125543-F5556A35-1E9A-4747-BFD6-58502A3ABB20Q35195102-F7A39500-DF72-45B6-A015-87CA018581CDQ35448351-24C99466-AD2D-4564-A9CC-9225B88D0555Q35624432-731A7D63-FF67-4C03-BA98-64FCD8A9916FQ35840846-0FB5B776-5BF1-48E5-8CEE-6B21A151F3AFQ35924925-6E887368-233A-4750-9279-C5E793EBEFB5Q35963446-872AA910-65A3-461A-855A-A7EA26C1F70DQ36022768-E08D0B78-D9C7-46B2-9A70-556D42DD08EBQ36107953-73C3A58C-4601-410D-943F-0272804960F6Q36146400-DABF9C83-4A8E-4203-909A-B276FE76E338Q36195016-FBA949C4-B842-42C6-B112-5CEF7364989FQ36231756-79691082-8951-4171-82A6-96A005D32BD4Q36285716-FD049B3F-079E-4C22-8787-B7F695D4113AQ36344113-B5EE9DD3-8447-4150-886A-06AC5F49F8C1Q36488883-327357A7-B33B-438D-A767-81D2EA0B4070Q36488894-2C1A4045-63BA-4482-BF33-D47CD87E08E4Q36488905-DF511247-CDE0-4BEC-A87E-B43E320211A6
P2860
Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues.
@ast
Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues.
@en
type
label
Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues.
@ast
Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues.
@en
prefLabel
Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues.
@ast
Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues.
@en
P1433
P1476
Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues
@en
P2093
Patrick Schaerli
P304
P356
10.1016/J.MOLIMM.2004.06.040
P577
2004-11-23T00:00:00Z